State Of Wisconsin Investment Board Opti Nose, Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.69 - $7.09 $59,409 - $114,149	-16,100 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$3.58 - $7.44 $57,638 - $119,784	16,100 New	16,100 $120,000
Q1 2020 May 06, 2020	SELL	$3.49 - $9.2 $130,526 - $344,080	-37,400 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.75 - $8.38 $53,675 - $94,694	11,300 Added 43.3%	37,400 $262,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $3,840 - $6,564	600 Added 2.35%	26,100 $185,000
Q1 2019 May 13, 2019	BUY	$6.1 - $10.3 $35,380 - $59,740	5,800 Added 29.44%	25,500 $263,000
Q4 2018 Feb 11, 2019	BUY	$5.84 - $11.92 $18,104 - $36,952	3,100 Added 18.67%	19,700 $122,000
Q2 2018 Aug 03, 2018	BUY	$18.75 - $28.46 $311,250 - $472,436	16,600 New	16,600 $464,000

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $440M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.